- In September 2023, Boston Scientific announced the acquisition of Relievant Medsystems for usd 850 million, enhancing its portfolio with the Intracept Intraosseous Nerve Ablation System, designed to treat vertebrogenic pain. The system offers a minimally invasive procedure for chronic low back pain. The deal is expected to close in the first half of 2024.
- In April 2024, Medtronic announced FDA approval for its Inceptiv closed-loop rechargeable spinal cord stimulator (SCS) for chronic pain treatment. Inceptiv is the first SCS to automatically adjust stimulation based on real-time biological signals, ensuring optimal therapy. The device also offers 1.5T and 3T MRI access, enhancing patient comfort and outcomes.
